GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Farmaceutica Remedia SA (BSE:RMAH) » Definitions » Other Net Income (Loss)

Farmaceutica Remedia (BSE:RMAH) Other Net Income (Loss) : lei-0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Farmaceutica Remedia Other Net Income (Loss)?

Farmaceutica Remedia's Other Net Income (Loss) for the three months ended in Mar. 2024 was lei-0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was lei-0.0 Mil.

Farmaceutica Remedia's quarterly Other Net Income (Loss) increased from Sep. 2023 (lei-0.0 Mil) to Dec. 2023 (lei0.0 Mil) but then declined from Dec. 2023 (lei0.0 Mil) to Mar. 2024 (lei-0.0 Mil).

Farmaceutica Remedia's annual Other Net Income (Loss) stayed the same from Dec. 2021 (lei0.0 Mil) to Dec. 2022 (lei0.0 Mil) but then declined from Dec. 2022 (lei0.0 Mil) to Dec. 2023 (lei-0.0 Mil).


Farmaceutica Remedia Other Net Income (Loss) Historical Data

The historical data trend for Farmaceutica Remedia's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Farmaceutica Remedia Other Net Income (Loss) Chart

Farmaceutica Remedia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Farmaceutica Remedia Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Farmaceutica Remedia Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was lei-0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Farmaceutica Remedia Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Farmaceutica Remedia's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Farmaceutica Remedia (BSE:RMAH) Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.

Farmaceutica Remedia (BSE:RMAH) Headlines

No Headlines